Trials / Withdrawn
WithdrawnNCT01326117
Daily Tadalafil and Gastric Emptying Time in Diabetic Gastroparesis
- Status
- Withdrawn
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Mark Feinglos · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The investigators hypothesize that in adult patients with diabetic gastroparesis with Type 1 diabetes (HbA1c ≤ 10.5%), daily tadalafil use will significantly improve gastric emptying compared to baseline as measured by gastric emptying time.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | tadalafil | 7 days of Cialis for Daily Use (5mg) |
Timeline
- Start date
- 2011-04-01
- Primary completion
- 2013-12-01
- Completion
- 2013-12-01
- First posted
- 2011-03-30
- Last updated
- 2014-07-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01326117. Inclusion in this directory is not an endorsement.